Optimisation of Benzodiazepine Immunoassay Using β-Glucuronidase Enzymatic Hydrolysis: A Comparison of Five Different β-Glucuronidase Enzymes

Background: Hydrolysis improves the sensitivity of drug detection for drug classes such as opiates/opioids and benzodiazepines, which are highly metabolized by glucuronidation and sulfation and should be implemented in analytical procedures to convert conjugated metabolites into the free or unbound form. This study was aimed to compare different enzymes to make an informed decision. Methods: In this study, the CEDIA Benzodiazepine assay was compared with the LC-MS-MS method using 150 positive urine samples and 50 negative urine samples. The samples were analysed without adding any enzyme and then by adding different enzymes to compare their performance. Results: The Kura Escherichia coli enzyme performed better than the Roche Escherichia coli enzyme which had 20% false-positive results. Kura BG-100 enzyme performed well but Kura B-One enzyme performed better The Kura B-One enzyme had only 11.5% false-positive results. When double the volume of Kura B-One enzyme was used to test to see if it will have any impact on reducing the number of false negatives, it performed worse. Kura Turbo enzyme behaved similarly to Kura BG-100. Conclusions: The β-glucuronidase enzymes comparison allowed us to identify the Kura B-One enzyme as the enzyme of choice for our operation because it reduces the false positives from 20% to 11.5% when compared with the Roche enzyme. It also improved the detection of oxazepam. The Kura B-One enzyme has a short incubation time for hydrolysis when used with the LC-MS-MS method. As a result, we improved the overall turn-around time and reduced the number of false positives that needed confirmation. How to cite this paper: Mina, A., McNeice, L., Banukumar, S. and Vazquez, S. (2022) Optimisation of Benzodiazepine Immunoassay Using β-Glucuronidase Enzymatic Hydrolysis: A Comparison of Five Different β-Glucuronidase Enzymes. Journal of Biosciences and Medicines, 10, 7-15. https://doi.org/10.4236/jbm.2022.101002 Received: November 24, 2021 Accepted: January 7, 2022 Published: January 10, 2022 Copyright © 2022 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access


Introduction
Using β-glucuronidase is a preferred method of hydrolysis over acid-catalysed hydrolysis, which is known to induce benzodiazepine degradation and transformation to increase cross-reactivity [1] [2] [3]. Metabolised forms of benzodiazepines undergo a process called glucuronidation during metabolism that attaches a glucuronic acid for increased solubility [4] [5]. β-glucuronidase is an enzyme that is used to de-conjugate β-glucuronides during urinary drug testing for benzodiazepines. Hydrolysis improves the sensitivity of drug detection for drug classes such as opiates/opioids and benzodiazepines, which are highly metabolized by glucuronidation and sulfation and should be implemented in analytical procedures to convert conjugated metabolites into the free or unbound form. Enzyme hydrolysis of urine using the β-glucuronidase to liberate conjugated drugs improves detectability [6] [7]. Only trace amounts of parent benzodiazepines are present in urine following extensive metabolism and conjugation [8]. It is also important to understand the difference between different immunoassays methods and what they can detect and if there are any limitations [9]. The Thermo Fisher CEDIA high sensitivity assay performed better when compared to other immunoassays [10] [11]. This study compared five different enzymes with the CEDIA immunoassay. The enzymes tested are β-glucuronidase from Escherichia coli from Roche and four different enzymes are obtained from Finden Kura which are B-One β-Glucuronidase, BG-100 β-Glucuronidase, BG Turbo β-Glucuronidase, and β-Glucuronidase from Escherichia coli.

Results
The Kura Escherichia coli enzyme performed better than the Roche Escherichia coli enzyme which had 20% false-positive results. The false negatives were less when the Roche enzyme was used only because the false positives were much higher because the Roche enzyme elevated all the baseline of results in general.
Kura BG-100 enzyme performed well but Kura B-One enzyme performed better.
The Kura B-One enzyme had only 11.5% false-positive results. Consequently, the true negatives were better when the Kura B-One enzyme was used. When double the volume of Kura B-One enzyme was added to test if it will have any impact on reducing further the number of false negatives, it performed worse.
Kura Turbo enzyme behaved similarly to Kura BG-100. The results are summarised in Table 1.
The false negatives were mainly 7-Amino Clonazepam, 7-Aminonitrazepam and oxazepam. They were detected, but not up to the cut-off level to be reported as positive. Using the Kura B-One enzyme improved the detectability and the reporting of oxazepam only. According to the manufacturer, CEIA immunoassay cross-reactivity for 7-Amino Clonazepam is 39% at a concentration of 515 ng/mL and the cross-reactivity for 7-Aminonitrazepam is 44% at a concentration of 450 ng/mL as shown in Table 2. Serial dilutions of 7-Amino Clonazepam and 7-Aminonitrazepam standard materials were tested using the Kura BG100 and Kura B-One enzymes. The cross-reactivity and consequently detectability was improved at a concentration of 62.5 ng/mL for 7-Amino Clonazepam and 7-Aminonitrazepam as shown in Table 3.   [14]. Enzyme preparations from Escherichia coli, Helix pomatia, and Patella vulgate were examined and found capable of reducing oxazepam or oxazepam glucuronide into nordiazepam (desmethyldiazepam).

Discussion
Nordiazepam formation was positively correlated with incubation temperature, incubation time, oxazepam concentration, and enzyme concentration. A study found that enzymatic hydrolysis using β-glucuronidase enzymes (Escherichia coli, Helix pomatia, and Patella vulgate) caused < 2.5% nordiazepam formation that was relative to the amount of oxazepam present in the system [15]. This unusual reductive transformation also occurs in other benzodiazepines with a hydroxyl group at the C3 position and converting temazepam into diazepam and lorazepam into delorazepam by about 1% [16]. These findings are suggesting the detection of nordiazepam, diazepam or delorazepam in biological samples subjected to testing involving enzyme-catalyzed hydrolysis should be interpreted with care. Another study found that after enzymatic hydrolysis of the urine samples, a 2 -19-fold increase in the concentration of the designer benzodiazepines flubromazolam was found, highlighting the value of hydrolysis for this analyte [17]. It was shown in another study that the amount of 7-amino-flunitrazepam metabolite quantitated by GC-MS, however, accounted for only 15% -20% of the total OnLine immunoassay crossreactive flunitrazepam metabolites [18].
Another study evaluated EMIT, EPIA, and Online immunoassays with the GC-MS method and although differences in the performances of the investigated assay systems were observed, they all seem appropriate for clinical use in detecting benzodiazepine intake in drug abusers when enzymatic hydrolysis is included [19].
In this study, the Roche enzyme has 20% false-positive results, while the Kura B-One enzyme has 11.5% false positive. Consequently, the true negative was im- with the assay. There are methods described to measure 7-aminonitrazepam using HPLC also [20]. The prospects of this study should help other laboratories to choose an enzyme that suits their needs and workflow. Also to realise the differences between these enzymes.

Conclusion
The β-glucuronidase enzyme comparison allowed us to identify the Kura B-One enzyme as the enzyme of choice for our operation because it reduces the false positives from 20% to 11.5% when compared with the Roche enzyme. As a result, the number of samples that need to go for confirmation on LC-MS-MS was reduced. It also improved the detection of oxazepam, 7-Amino Clonazepam and 7-Aminonitrazepam. Additionally, it has the least incubation time for hydrolysis when also used for confirmation using LC-MS/MS method which improved the overall turn-around time.